Former Edwards CSO head and TAVR pioneer Stan Rowe is teaming up with deep-pocketed Deerfield Management to create a new innovation center that solves the problem most incubators face: finding sufficient capital to survive early development efforts.Subscribe now to read the full analysis
Welcome to MyStrategist, an online experience like no other in the medical device industry.
MedTech Strategist, the industry's most trusted resource, will help you stay ahead of the opportunities and obstacles that are impacting your corporate strategy. We invite you to explore our coverage. Think Strategically. Subscribe Today.Subscribe Browse
Discover the opportunities and challenges that impact the global medtech regulatory and reimbursement community with MedTech Strategist Market Pathways.Subscribe Free Premier Issue Learn More
Migraine medications come with side effects and contraindications that limit the amount that can be used safely at a time, and the next best alternative involves direct neural stimulation delivered by surgically-implanted electrodes. Neurolief has introduced the Relivion, the first non-invasive, multi-channel wearable neuromodulation headset that taps into the brain's occipital and trigeminal neural pathways to stop and prevent migraine episodes.Subscribe now to read the full analysis
Our strategic publications provide actionable intelligence to support each member of your organization. Check to see if your company has access.Learn More
Results from L.E.K. Consulting's latest annual survey of health system and hospital executives. By Ilya Trakhtenberg, Jonas Funk, and Monish Rajpal, L.E.K. Consulting.Subscribe now to read the full analysis